Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity
Authors:
- Cora WeigertCWCora Weigert
- Harald StaigerHSHarald Staiger
- Kilian RittigKRKilian Rittig
- Alexander CeganACAlexander Cegan
- Philipp LutzPLPhilipp Lutz
- Fausto MachicaoFMFausto Machicao
- Hans-Ulrich HäringHHHans-Ulrich Häring
- Erwin SchleicherESErwin Schleicher
- 1 August 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 295 (2) , E339-E349
Abstract
Endothelial lipotoxicity has been implicated in the pathogenesis of multiple stages of cardiovascular disease from early endothelial dysfunction to manifest atherosclerosis and its complications. Saturated free fatty acids are the major inducers of endothelial cell apoptosis and inflammatory cytokines. In humans, the enzyme human stearoyl-CoA desaturase-1 (hSCD-1) is the limiting step of the desaturation of saturated to monounsaturated fatty acids. Since we could demonstrate the expression of SCD-1 in primary human arterial endothelial cells (HAECs), we aimed to prove a beneficial role of upregulated hSCD-1 expression. In contrast to other cells that are less susceptible to lipotoxicity, hSCD-1 was not upregulated in HAECs upon palmitate treatment. Following that, we could show that upregulation of hSCD-1 using the LXR activator TO-901317 in HAECs protects the cells against palmitate-induced lipotoxicity, cell apoptosis, and expression of inflammatory cytokines IL-6 and IL-8. Increased hSCD-1 activity was determined as increased C16:1/16:0 ratio and enhanced triglyceride storage in palmitate treated cells. The beneficial effect was clearly attributed to enhanced hSCD-1 activity. Overexpression of hSCD-1 blocked palmitate-induced cytotoxicity, and knockdown of hSCD-1 using siRNA abolished the protective effect of TO-901317 in HEK-293 cells. Additionally, inhibition of hSCD-1 with 10/12 CLA blocked the effect of TO-901317 on palmitate-induced lipotoxicity, cell apoptosis, and inflammatory cytokine induction in HAECs. We conclude that upregulation of hSCD-1 leads to a desaturation of saturated fatty acids and facilitates their esterification and storage, thereby preventing downstream effects of lipotoxicity in HAECs. These findings add a novel aspect to the atheroprotective actions of LXR activators in cardiovascular disease.Keywords
This publication has 59 references indexed in Scilit:
- Laminar shear stress up-regulates the expression of stearoyl-CoA desaturase-1 in vascular endothelial cellsCardiovascular Research, 2007
- Liver X Receptor Inhibits the Synthesis and Secretion of Apolipoprotein A1 by Human Liver-Derived CellsBiochemistry, 2006
- Stearoyl-Coenzyme A Desaturase 1 Deficiency Protects against Hypertriglyceridemia and Increases Plasma High-Density Lipoprotein Cholesterol Induced by Liver X Receptor ActivationMolecular and Cellular Biology, 2006
- Probing the role of stearoyl-CoA desaturase_1 in hepatic insulin resistanceJournal of Clinical Investigation, 2006
- Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistanceJournal of Clinical Investigation, 2006
- Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolismEuropean Heart Journal Supplements, 2006
- Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?Diabetes & Metabolism, 2006
- In vitro endothelial cell susceptibility to xenobiotics: Comparison of three cell typesCell Biology and Toxicology, 2005
- AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndromeMedical Hypotheses, 2005
- Effect of the Pattern of Elevated Free Fatty Acids on Insulin Sensitivity and Insulin Secretion in Healthy HumansHormone and Metabolic Research, 2001